"Sympatholytics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here.
| Descriptor ID |
D013565
|
| MeSH Number(s) |
D27.505.696.663.050.850
|
| Concept/Terms |
Sympatholytics- Sympatholytics
- Sympatholytic Agents
- Agents, Sympatholytic
- Sympatholytic Drugs
- Drugs, Sympatholytic
- Sympathetic-Blocking Agents
- Agents, Sympathetic-Blocking
- Sympathetic Blocking Agents
Sympatholytic Effect- Sympatholytic Effect
- Effect, Sympatholytic
- Sympatholytic Effects
- Effects, Sympatholytic
|
Below are MeSH descriptors whose meaning is more general than "Sympatholytics".
Below are MeSH descriptors whose meaning is more specific than "Sympatholytics".
This graph shows the total number of publications written about "Sympatholytics" by people in this website by year, and whether "Sympatholytics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sympatholytics" by people in Profiles.
-
Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharm Res. 1999 Sep; 16(9):1352-9.
-
Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain. Anesthesiology. 1998 Aug; 89(2):493-9.
-
Doxazosin: a new approach to hypertension and benign prostatic hyperplasia. Br J Clin Pract. 1996 Apr-May; 50(3):154-63.
-
Adrenergic and serotonergic regulation of skeletal muscle metabolism in rat. I. The effects of adrenergic and serotonergic antagonists on the regulation of muscle amino acid release, glycogenolysis, and cyclic nucleotide levels. J Biol Chem. 1983 Oct 25; 258(20):12494-8.
-
Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976 Sep 09; 295(11):573-7.